https://www.gloucestershirelive.co.uk/news/health/new-bowel-cancer-drug-found-9320411
A new #immunotherapy #cancer #drug, GSK's dostarlimab, has been found in a 42-patient clinical trial at Memorial Sloan Kettering Cancer Centre to be 100% effective against mismatch repair deficient (dMMR) #rectal #cancer. Every single one of the 42 trial patients is now in complete #remission.